Pharmacist Management of Attention Deficit Hyperactivity Disorder Medication Refill Requests

NCT06388694 | Completed

• 1 other identifier: RDO KPNC 24-056
• Study Type: interventional
• Target: 315
• Locations: 1 country
• Sites: 1

Brief Summary

This cluster randomized trial will compare pharmacist management of secure message requests for refills of attention deficit hyperactivity medications with primary care physician management regarding quality of care, timeliness of service, and parent care experience.

Conditions

Attention-deficit Hyperactivity

Outcome Measures

Primary Outcomes (1)

• Percentage of participants appropriately referred for a follow-up weight check

  Percentage of participants referred for a follow-up visit for a weight check, among those who had not had a weight check in the 6 months prior to the medication refill request

  within 7 days after the refill request

Secondary Outcomes (2)

• Timeliness of care

  within 14 days after the refill request

• Parent perception of effectiveness of care

  within 3 weeks after the refill request

Study Arms (2)

Pharmacist Care

EXPERIMENTAL

Pharmacists will provide ADHD medication refill orders in response to secure message requests by parents, under the authorization of appropriate physicians.

Other: Pharmacist Care

Primary Care Physician Care

ACTIVE COMPARATOR

Primary care pediatricians will provide ADHD medication refill orders in response to secure message requests by parents.

Other: Primary Care Physician Care

Interventions

Pharmacist Care OTHER

Pharmacists will provide ADHD medication refill orders in response to secure message requests by parents, under the authorization of appropriate physicians.

Pharmacist Care

Primary Care Physician Care OTHER

Primary care pediatricians will provide ADHD medication refill orders in response to secure message requests by parents. This is usual care.

Primary Care Physician Care

Eligibility Criteria

• Age: 2 Years - 17 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17)

You may qualify if:

• Parent or caregiver requested an ADHD medication refill via a secure message

You may not qualify if:

• The ADHD medication refill request was not straightforward and had to be handled by the primary care provider (and thus not eligible for random assignment to Pharmacist Care or PCP Care)

Sponsors & Collaborators

• Kaiser Permanente: lead

Study Sites (1)

Kaiser Permanente Northern California

Oakland, California, 94612, United States

Location

Related Publications (1)

• Lieu TA, Parry D, deLaunay A, Margaret Warton E, Prausnitz S, Ahmed O, Mancha MR, Smallberg E, Quesenberry C, Lee K, Reed M; Permanente Medical Group Virtual Care Study Team. Pharmacist care for attention-deficit/hyperactivity disorder electronic medication refills: A cluster randomized trial. J Manag Care Spec Pharm. 2025 Nov;31(11):1156-1165. doi: 10.18553/jmcp.2025.31.11.1156.

  PMID: 41171067 DERIVED

MeSH Terms

Interventions

Physicians, Primary Care

Intervention Hierarchy (Ancestors)

Physicians; Health Personnel; Health Care Facilities Workforce and Services

Study Officials

• Tracy A Lieu

  Kaiser Permanente Northern California Division of Research

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: INVESTIGATOR
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: April 22, 2024
• First Posted: April 29, 2024
• Study Start: May 6, 2024
• Primary Completion: June 21, 2024
• Study Completion: July 31, 2024
• Last Updated: August 30, 2024

Record last verified: 2024-08

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)